HARMONY BIOSCIENCES HOLDINGS (HRMY)
US4131971040 - Common Stock
ChartMill assigns a Buy % Consensus number of 77% to HRMY. The Buy consensus is the weighted average rating of the current analysts ratings.
Analysts have set a mean price target forecast of 45.01. This target is 35.44% above the current price.
HRMY was analyzed by 15 analysts. The buy percentage consensus is at 77. So analysts seem to be have mildly positive about HRMY.
In the previous month the buy percentage consensus was at a similar level.
HRMY was analyzed by 15 analysts, which is quite many. So the average rating should be quite meaningful.
Price Target & Forecast
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2024-10-30 | Cantor Fitzgerald | Maintains | Overweight -> Overweight |
| 2024-10-30 | Needham | Reiterate | Buy -> Buy |
| 2024-10-30 | Oppenheimer | Reiterate | Outperform -> Outperform |
| 2024-10-29 | Needham | Reiterate | Buy -> Buy |
| 2024-10-10 | Mizuho | Maintains | Outperform -> Outperform |
| 2024-10-10 | Raymond James | Reiterate | Outperform |
| 2024-10-02 | Needham | Reiterate | Buy -> Buy |
| 2024-09-24 | Needham | Reiterate | Buy -> Buy |
| 2024-09-12 | Needham | Reiterate | Buy -> Buy |
| 2024-09-10 | UBS | Initiate | Buy |
| 2024-08-08 | Needham | Reiterate | Buy -> Buy |
| 2024-08-06 | Needham | Reiterate | Buy -> Buy |
| 2024-06-25 | Needham | Reiterate | Buy -> Buy |
| 2024-06-24 | Needham | Reiterate | Buy -> Buy |
| 2024-06-21 | Citigroup | Initiate | Buy |
| 2024-05-01 | Needham | Maintains | Buy -> Buy |
| 2024-04-30 | Needham | Reiterate | Buy -> Buy |
| 2024-04-12 | Cantor Fitzgerald | Reiterate | Overweight -> Overweight |
| 2024-04-11 | Needham | Reiterate | Buy -> Buy |
| 2024-04-09 | Needham | Reiterate | Buy -> Buy |
| 2024-03-28 | Cantor Fitzgerald | Reiterate | Overweight -> Overweight |
| 2024-02-27 | Mizuho | Maintains | Buy -> Buy |
| 2024-02-23 | Cantor Fitzgerald | Reiterate | Overweight -> Overweight |
| 2024-02-23 | Needham | Maintains | Buy -> Buy |
| 2024-02-22 | Needham | Reiterate | Buy -> Buy |
| 2024-02-16 | Mizuho | Maintains | Buy -> Buy |
| 2024-01-09 | Goldman Sachs | Maintains | Sell -> Sell |
| 2024-01-02 | B of A Securities | Downgrade | Neutral -> Underperform |
| 2023-11-01 | Needham | Reiterate | Buy -> Buy |
| 2023-11-01 | Raymond James | Maintains | Outperform -> Outperform |